Our History

Alpharmaxim's heritage

Alpharmaxim – a healthcare communications company with experience and pedigree

Since its formation in 2001, Alpharmaxim has worked with pharmaceutical clients big and small, helping them to develop an effective narrative they can use to maximise their communications.

Across multiple therapeutic areas, but with a focus on speciality medicines, Alpharmaxim has grown though its ability to provide trusted support for healthcare clients – helping them to fulfil their promises and make a difference.

Take a look at some of the highlights we have had in working with our clients to produce empowering healthcare communications through our use of insightful strategy and solution-focused programmes.

  • 2001
    May 2001

    Alpharmaxim opens its doors for the first time

    Driven by a desire to develop narratives that could effectively shape medical communications for their clients, Alpharmaxim was formed by Will Hind and Amanda Price – both of whom still run the company today.

  • 2002
    March 2002

    First work in vaccines

    Almost immediately, Alpharmaxim started to work on communication plans for vaccines. Initially working with primary paediatric vaccinations, the portfolio has expanded to encompass rabies, influenza, and travel vaccines.

  • 2009
    May 2009

    Rare diseases

    Alpharmaxim has always focused on speciality medicine and the last 10 years has seen an increase in the importance of rare diseases. Whether in lysosomal storage disease, heritary angioedema, Meniere’s disease, amyloidosis or Short Bowel Syndrome, Alpharmaxim has provided clients with the ability to identify and communicate with physicians and patients alike.

  • 2016
    June 2016

    Internal communications

    Alpharmaxim is one of the few healthcare communications companies with a specialised team dedicated to internal communications. With copywriters from journalistic backgrounds, Alpharmaxim has provided internal and investor communications to some of the biggest companies in the pharmaceutical industry. In 2016, they won the IC Brilliance Silver Award for Best Internal Communication Campaign for their work with AstraZeneca

    http://boc-uk.com/awards/ic-brilliance-awards/winners-2016/

  • 2017
    June 2017

    Immunotherapy - new frontiers in medicine?

    Immunotherapy is on the cusp of providing scientific breakthroughs across a range of diseases. Alpharmaxim is working closely with a number of clients whose products provide new hope in the treatment of old diseases.

Meet our team

Let us introduce our team. Say hello to the people behind Alpharmaxim.

Join our Team

We’re always on the lookout for the best talent to join our exceptional team.